Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.33 |
| ▸ | TACR2 | P21452 | 1/20 | 0.32 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | GYPA | P02724 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.30 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31124807 | 0.77 | SLC6A2 (0.46) | SLC6A2LGALS8PDPK1MTORPDE4D | |
| SCHEMBL6559094 | 0.77 | SLC6A2 (0.49) | SLC6A2LGALS8LGALS3SLC5A1SLC5A2 | |
| SCHEMBL10148704 | 0.77 | SLC6A2 (0.49) | SLC6A2LGALS8LGALS3SLC5A1SLC5A2 | |
| SCHEMBL6559086 | 0.77 | SLC6A2 (0.49) | SLC6A2LGALS8LGALS3SLC5A1SLC5A2 | |
| SCHEMBL5688958 | 0.73 | SLC6A2 (0.43) | SLC6A2LGALS8PDPK1MTORPDE4D | |
| SCHEMBL11981204 | 0.73 | SLC6A2 (0.45) | SLC6A2LGALS8PDE4DLGALS3SLC5A1 | |
| SCHEMBL28208353 | 0.73 | PDPK1 (0.40) | SLC6A2PDPK1MTORPDE4DTACR2 | |
| SCHEMBL7794201 | 0.70 | SLC5A2 (0.41) | SLC6A2LGALS8SSTR5SLC5A1SLC5A2 | |
| SCHEMBL8519782 | 0.70 | BCHE (0.33) | PDPK1MTORGRM2GRM3 | |
| SCHEMBL14490088 | 0.70 | SLC6A2 (0.38) | SLC6A2LGALS8TACR2SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120208993-A1 | SYNTHETIC HEPARIN TRISACCHARIDES | ALCHEMIA LIMITED (AU) | 2012-08-16 | — | — | US | disclosed |
| US-7541445-B2 | Synthetic heparin pentasaccharides | ALCHEMIA LIMITED (AU) | 2009-06-02 | — | — | US | disclosed |
| US-20050080042-A1 | synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease | DR. REDDY'S LABORATORIES, SA (CH) | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080042-A1 | synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease | HPSE, DDOST, STS | SLC6A2 3040/4885LGALS8 775/4885PDPK1 3033/4885 |
| US-20120208993-A1 | SYNTHETIC HEPARIN TRISACCHARIDES | HPSE, SERPINC1, DDOST | SLC6A2 4619/4885LGALS8 910/4885PDPK1 3823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.